New research has identified specific blood-borne molecules called piRNAs that predict two-year survival in older adults more accurately than chronological age or standard medical exams.
Researchers at Duke University and the University of Minnesota have identified a small set of “overlooked” genetic fragments in the bloodstream, known as piRNAs, that can predict with high accuracy whether an adult aged 71 or older will survive the next two years. The study, published in the journal Aging Cell, analyzed blood samples from 1,271 diverse participants more than half of whom were Black and found that a model using just six piRNAs “substantially outperformed age alone,” which performed only slightly better than chance in external testing.
While chronological age has traditionally been the primary metric for longevity, this research suggests that these tiny molecules, once thought to function only in reproductive cells, actually regulate biological processes like cellular stress and immune response. Although the predictive power of the test diminished over five- and ten-year horizons, the specific molecular markers performed comparably to or better than current clinical models that rely on “6 to 25 physician-reported factors.” Scientists now view these nine identified piRNAs as potential drug targets, noting that while therapeutic applications remain hypothetical, “biological markers may tell us more about short-term survival than chronological age alone.”